News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Exco Intouch Achieve A New First In Mobile Clinical Technology


9/2/2014 2:20:51 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

2 September 2014 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers today announced a new first in the clinical technology arena. Having pioneered the use of mobile technology, increasing retention and compliance through engaging and supporting patients, and facilitating the delivery of ePRO via mobile devices, the forward looking company are now the only electronic Clinical Outcomes Assessment (eCOA) provider to have published public-facing apps on all three mobile operating platforms (iOS, Android and Windows8).

Dale Jessop, CTO at Exco InTouch, commented: “We’re thrilled to have reached this milestone, and even more so having used native apps, as this provides the user with device specific natural controls - driving familiarity and ease of use. Currently the most common approach is to use HTML5, which wraps a web app into mobile operating controls, however, this does not enable the layout to be optimized for the device in use, or incorporate natural button configurations and so does not present the best experience for patients. In contrast, our pedigree in developing mobile solutions for clinical and healthcare programs has enabled us to deliver the benefits of native apps in a timely, cost effective manner across all platforms.”

The variety of apps developed for clients by Exco InTouch covers a broad range of therapeutic areas; from cardiovascular and respiratory diseases through to smoking cessation and vaccination programs, utilizing their flexible platform which adapts to individual program needs. The platform enables the integration of medical device data and also lifestyle devices, such as FitBit™, which are increasingly popular in clinical research to provide secondary outcomes data.

The company’s leading approach enables its clients to select their preferred delivery model, offering the flexibility to either provision appropriate devices for the study population, or more significantly to enable BYOD (Bring Your Own Device) in both clinical and commercial programs. This is enabled by proprietary mDNA® technology, which provides sponsors and payers the robust reassurance of protecting Personally Identifiable Information (PII) and maintaining data security even when using the patients’ own devices.

Tim Davis, CEO and founder of Exco InTouch, commented: “We are leading the way in delivering native apps across all three mobile operating platforms, which not only is an achievement for our company, but also another great milestone for the entire clinical industry. There is huge demand in the industry for eCOA providers to deliver user friendly solutions that the patient finds easy to use and accessible. A clinical trial is reliant on timely engagement from its patients and we are delighted to be foremost in improving patients’ user experience.”

For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 203 6740 or e-mail: t.jervis@defacto.com.

-ENDS-

Exco InTouch is the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Using a combination of software and services, Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes for sponsors, clinical research organizations, sites and patients.

Working across clinical and late phase trials and mHealth programs, Exco InTouch’s device independent approach enables involvement which integrates into daily life - resulting in motivated and compliant patients, reducing costs associated with withdrawals from trials and improving overall program results.

Since 2004, Exco InTouch has engaged with over 900,000 subjects across 85 countries, over 15,000 hospitals and clinics, in 70 languages. 16 of the top 20 pharmaceutical companies have deployed our trusted applications in the knowledge that data is secure and protected, in line with global regulatory and data protection requirements

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES